This work was supported by grants from the Parkinson's disease Foundation; Department of Veterans Affairs (1I01BX000531), National Institutes of Health (P50 NS062684, R01 NS065070 and R25 TW009345), Fondo de Investigacion Sanitaria (FIS, PI11/00228, PFIS, FI 11/00259, IFIMAV, and WLA 04/11), Instituto de Salud Carlos III (PI11/00093 and PI08/0915), Spanish Ministry of Economy and Competitiveness, European Social Fund, and the Asociación Parkinson Asturias.Peer reviewe
The Leucine-Rich Repeat Kinase 2 (LRRK2) Gly2019Ser mutation is frequent among Parkinson's disease (...
Objective: Recently understanding genetic forms and pathogenic mutations has been providing growing ...
Background and PurposeaaThe LRRK2 (PARK8; OMIM607060) substitution was recently identified as a caus...
BACKGROUND: Mutations in the genes PRKN and LRRK2 are the most frequent known genetic lesions among ...
LRRK2 mutations have recently been described in families with Parkinson's disease. Here we show that...
OBJECTIVES: To determine clinical characteristics and frequency of leucine-rich repeat kinase 2 gene...
Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease, with frequenci...
Background: PARK8 is the most common known mendelian form of Parkinson's Disease (PD). It is due to ...
Mutations in the LRRK2 and GBA genes are increasingly recognized as frequent determinants of familia...
The identification of the leucine-rich repeat kinase 2 (LRRK2) gene was a breakthrough in the area o...
Premio Sociedad Andaluza de Neurología al proyecto “Polimorfismos genéticos, biomarcadores plasmátic...
Background: Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of P...
Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s di...
Copyright © 2014 Aroma Agape Gopalai et al. This is an open access article distributed under the Cre...
BACKGROUND: Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of P...
The Leucine-Rich Repeat Kinase 2 (LRRK2) Gly2019Ser mutation is frequent among Parkinson's disease (...
Objective: Recently understanding genetic forms and pathogenic mutations has been providing growing ...
Background and PurposeaaThe LRRK2 (PARK8; OMIM607060) substitution was recently identified as a caus...
BACKGROUND: Mutations in the genes PRKN and LRRK2 are the most frequent known genetic lesions among ...
LRRK2 mutations have recently been described in families with Parkinson's disease. Here we show that...
OBJECTIVES: To determine clinical characteristics and frequency of leucine-rich repeat kinase 2 gene...
Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease, with frequenci...
Background: PARK8 is the most common known mendelian form of Parkinson's Disease (PD). It is due to ...
Mutations in the LRRK2 and GBA genes are increasingly recognized as frequent determinants of familia...
The identification of the leucine-rich repeat kinase 2 (LRRK2) gene was a breakthrough in the area o...
Premio Sociedad Andaluza de Neurología al proyecto “Polimorfismos genéticos, biomarcadores plasmátic...
Background: Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of P...
Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s di...
Copyright © 2014 Aroma Agape Gopalai et al. This is an open access article distributed under the Cre...
BACKGROUND: Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of P...
The Leucine-Rich Repeat Kinase 2 (LRRK2) Gly2019Ser mutation is frequent among Parkinson's disease (...
Objective: Recently understanding genetic forms and pathogenic mutations has been providing growing ...
Background and PurposeaaThe LRRK2 (PARK8; OMIM607060) substitution was recently identified as a caus...